Diclofenac topical formulation with a high absorption rate
AssigneeIbsa Institut Biochimique SA
InventorsNadia Puppini, Valentina Nicolini, Tiziano Fossati
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions for topical use containing diclofenac in the form of salt with epolamine, present at concentrations higher than 2.0% by weight are described. Such compositions provide, with respect to those currently available, a more complete absorption of the administered dose, reducing the dispersion of active ingredient and allowing treatments requiring the administration of high and accurate dosages to be carried out.
Claims6
A pharmaceutical composition for topical use comprising diclofenac in the form of salt with epolamine, diclofenac-epolamine, at a concentration of 2.6% by weight, based on the weight of the composition1, the composition comprising lecithin in a weight ratio ranging from 0.5:1 to 0.9:1 with respect to the diclofenac-epolamine salt.
Dependencies are inferred from the claim text.